Esteves F, Rueff J, Kranendonk M
J Xenobiot. 2021; 11(3):94-114.
PMID: 34206277
PMC: 8293344.
DOI: 10.3390/jox11030007.
Guengerich F
Toxicol Res. 2020; 37(1):1-23.
PMID: 32837681
PMC: 7431904.
DOI: 10.1007/s43188-020-00056-z.
Pinto N, Dolan M
Curr Drug Metab. 2011; 12(5):487-97.
PMID: 21453273
PMC: 3110519.
DOI: 10.2174/138920011795495321.
Yengi L, Leung L, Kao J
Pharm Res. 2007; 24(5):842-58.
PMID: 17333392
DOI: 10.1007/s11095-006-9217-9.
Kotake A, Funae Y
Proc Natl Acad Sci U S A. 1980; 77(11):6473-5.
PMID: 6935662
PMC: 350307.
DOI: 10.1073/pnas.77.11.6473.
Induction of drug-metabolizing enzymes and cytochrome P-450.
Long R
Biochem J. 1969; 115(5):26P.
PMID: 5360681
PMC: 1185256.
DOI: 10.1042/bj1150026p.
Electron paramagnetic resonance study of the high- and low-spin forms of cytochrome P-450 in liver and in liver microsomes from a methylcholanthrene-treated rabbit.
Peisach J, Blumberg W
Proc Natl Acad Sci U S A. 1970; 67(1):172-9.
PMID: 4318775
PMC: 283184.
DOI: 10.1073/pnas.67.1.172.
Effect of mirex on the activities of various rat hepatic mixed-function oxidases.
Mehendale H, Chen P, Fishbein L, Matthews H
Arch Environ Contam Toxicol. 1973; 1(3):245-54.
PMID: 4204629
DOI: 10.1007/BF01985747.
Polychlorinated biphenyls: a new type of inducer of cytochrome P-448 in the liver.
Alvares A, Bickers D, Kappas A
Proc Natl Acad Sci U S A. 1973; 70(5):1321-5.
PMID: 4197089
PMC: 433488.
DOI: 10.1073/pnas.70.5.1321.
Theophylline and antipyrine disposition in smoking and non-smoking epileptic subjects.
Acheson D, Uden S, Braganza J, Brown S, Houston J
Br J Clin Pharmacol. 1987; 24(6):812-5.
PMID: 3440101
PMC: 1386408.
DOI: 10.1111/j.1365-2125.1987.tb03250.x.
Effect of whole-body hyperthermia on hepatic cytochrome P450.
Neville A, Singh G
Cancer Chemother Pharmacol. 1990; 25(5):342-4.
PMID: 2306794
DOI: 10.1007/BF00686234.
Metabolic activation of aromatic hydrocarbons in purified rat liver nuclei: induction of enzyme activities and binding to DNA with and without monooxygenase-catalyzed formation of active oxygen.
Rogan E, Mailander P, Cavalieri E
Proc Natl Acad Sci U S A. 1976; 73(2):457-61.
PMID: 813227
PMC: 335928.
DOI: 10.1073/pnas.73.2.457.
The drug metabolism systems of liver and liver tumors: a comparison of activities and characteristics.
Strobel H, Dignam J, Saine S, Fang W, Fennell P
Mol Cell Biochem. 1978; 22(2-3):79-91.
PMID: 745599
DOI: 10.1007/BF00496236.
Characteristics of the rat liver microsomal enzyme system converting cholecalciferol into 25-hydroxycholecalciferol. Evidence for the participation of cytochrome p-450.
Madhok T, DeLuca H
Biochem J. 1979; 184(3):491-9.
PMID: 231972
PMC: 1161830.
DOI: 10.1042/bj1840491.
Characteristics of cytochrome P-450 and mixed function oxidase enzymes following treatment with PBBs.
Dent J
Environ Health Perspect. 1978; 23:301-7.
PMID: 209991
PMC: 1637476.
DOI: 10.1289/ehp.7823301.
Effect of polybrominated biphenyls on hepatic excretory function in rats and mice.
Cagen S, Gibson J
Environ Health Perspect. 1978; 23:233-9.
PMID: 209981
PMC: 1637484.
DOI: 10.1289/ehp.7823233.
Uridine-cytidine kinase. III. Competition between uridine and cytidine for a single enzyme.
Liacouras A, ANDERSON E
Mol Cell Biochem. 1977; 17(3):141-6.
PMID: 200838
DOI: 10.1007/BF01730833.
